GPCRs session icon

Can platelet purinergic receptors be targeted to safely treat non-thrombotic diseases?

  • Chair(s):

    Clive Page,
    Professor of Pharmacology,King's College London, London, United Kingdom

    Dingxin Pan,
    Postdoctoral Fellow,King's College London, London, United Kingdom

  • Session description:

    Platelet activation during inflammation and evidence for biased signalling via P2Y1
    Dr Simon Pitchford
    Reader in Immunopharmacology, King's College London, London, United Kingdom

    The role of the platelet P2Y12 receptor in inflammation
    Professor Robert Storey
    Professor of Cardiology, University of Sheffield, Sheffield, United Kingdom

    Oral communication speaker - to be confirmed in 2023

    The Role of P2Y1 and P2Y14 receptors in non-thrombotic platelet functions
    Kate Arkless
    King's College London, United Kingdom

    Probing P2Y1, P2Y12 and P2Y14 receptors with novel ligands and their potential therapeutic use
    Dr Kenneth A. Jacobson
    Senior Investigator, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, USA

    Sponsored by

    the British Journal of Pharmacology


03 Jul 2023


9:45 am - 12:10 pm


Go to Top